Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: FVT, SHM

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders


SAN JOSE, Calif., March 2, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its CEO, Dr. Amit Kumar, will provide a corporate presentation on the company, its business model, and updates on each of its programs and will host a question and answer period after Anixa's 2023 Annual Meeting of Stockholders, being held at 10:00AM PST on March 9, 2023 in a virtual format.

Shareholders and all other interested parties may attend the meeting by going to www.virtualshareholdermeeting.com/ANIX2023. 

About Anixa Biosciences, Inc.

Anixa is a clinical-stage biotechnology company with programs addressing cancer and infectious disease.  Anixa's portfolio of therapeutics includes a cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and, with partner MolGenie GmbH, a COVID-19 program focused on compounds targeting the Mpro enzyme of SARS-CoV-2, which is largely conserved across all recently identified variants.  The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer ? specifically triple negative breast cancer (TNBC), the most lethal form of the disease ? as well as a vaccine to prevent ovarian cancer.  These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer.  Anixa's unique business model of partnering with world-renowned research institutions on clinical development allows the company to continually examine emerging technologies in complementary fields for further development and commercialization.  To learn more, visit www.anixa.com or follow Anixa on Twitter, LinkedIn, Facebook and YouTube.

Contact:
Mike Catelani
[email protected]
408-708-9808

SOURCE Anixa Biosciences, Inc.


These press releases may also interest you

at 21:56
OKX Marketplace Introduces Zero-Fee Trading for Runes Following Bitcoin Halving
OKX, a leading Web3 technology company, today added support for Runes, a new fungible token standard by Casey Rodarmor, a former Bitcoin developer and artist, following today's Bitcoin halving. With this addition, users can now create, mint, manage...

at 19:50
Faraday Future Receives Letter from Nasdaq Regarding Form 10-K Filing
Faraday Future Intelligent Electric Inc. ("Faraday Future" or the "Company") , a California-based global shared intelligent electric mobility ecosystem company, today announced that it received a letter (the "Nasdaq Letter") from The Nasdaq Stock...

at 19:50
Genifi Announces Full Year and Q4 2023 Results
Genifi Inc. (formerly Prodigy Ventures Inc.) ("genifi" or the "Company") today announced its financial results for the three months and year ended December 31, 2023. As previously reported, the Company sold TCB Corporation ("Prodigy Labs") on...

at 19:47
Sabre announces upcoming webcasts of its 2024 Annual Meeting of Stockholders and first quarter 2024 earnings conference call
Sabre Corporation ("Sabre") announced plans to host a live webcast of its 2024 Annual Meeting of Stockholders on April 24, 2024 at 10:30 a.m. ET.  The webcast will be accessible by visiting the Investor Relations section of Sabre's website...

at 19:38
Illinois Speaker Chris Welch Recommended by Proviso Township Democratic Organization to Serve as Committeeman
Illinois House Speaker Emanuel "Chris" Welch was unanimously recommended to serve as the new Proviso Township Committeeman in a meeting held Friday evening of the Executive Committee, replacing the late Karen Yarbrough....

at 19:08
Nium and Kapronasia Partner to Shed Light on Cross-border B2B Payment Challenges in Asia
Nium, the global leader in real-time, cross-border payments, and Asia's leading payments, banking, and capital markets research firm, Kapronasia, today launched "Breaking Borders: The Revolution of Real-Time Cross-Border B2B Payments in Asia" - a new...

More news about Science and technology...


News published on and distributed by: